HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Todd Parsley Selected Research

SYN-004

1/2019Identification, Characterization, and Formulation of a Novel Carbapenemase Intended to Prevent Antibiotic-Mediated Gut Dysbiosis.
10/2016Development of SYN-004, an oral beta-lactamase treatment to protect the gut microbiome from antibiotic-mediated damage and prevent Clostridium difficile infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Todd Parsley Research Topics

Disease

2Dysbiosis
01/2019 - 10/2016
1Opportunistic Infections (Opportunistic Infection)
01/2019
1Clostridium Infections
10/2016
1Diarrhea
10/2016

Drug/Important Bio-Agent (IBA)

2SYN-004IBA
01/2019 - 10/2016
2Anti-Bacterial Agents (Antibiotics)IBA
01/2019 - 10/2016
2beta-Lactamases (beta-Lactamase)IBA
01/2019 - 10/2016
2EnzymesIBA
01/2019 - 10/2016
1carbapenemaseIBA
01/2019
1Ceftriaxone (Ceftriaxon)FDA LinkGeneric
01/2019